Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Alkermes Plc (ALKS)

Alkermes Plc (ALKS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,186,137
  • Shares Outstanding, K 164,901
  • Annual Sales, $ 1,558 M
  • Annual Income, $ 367,070 K
  • EBIT $ 391 M
  • EBITDA $ 420 M
  • 60-Month Beta 0.51
  • Price/Sales 3.33
  • Price/Cash Flow 11.85
  • Price/Book 3.43

Options Overview Details

View History
  • Implied Volatility 40.61% ( -1.91%)
  • Historical Volatility 41.33%
  • IV Percentile 49%
  • IV Rank 49.75%
  • IV High 77.52% on 04/10/25
  • IV Low 4.06% on 08/16/24
  • Put/Call Vol Ratio 3.10
  • Today's Volume 127
  • Volume Avg (30-Day) 254
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 6,469
  • Open Int (30-Day) 4,909

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 0.30
  • Number of Estimates 5
  • High Estimate 0.40
  • Low Estimate 0.19
  • Prior Year 0.60
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.70 +18.61%
on 04/21/25
31.99 -1.00%
on 05/02/25
+4.67 (+17.30%)
since 04/17/25
3-Month
25.56 +23.90%
on 04/10/25
35.79 -11.51%
on 02/21/25
-3.83 (-10.79%)
since 02/20/25
52-Week
22.90 +38.30%
on 07/10/24
36.45 -13.11%
on 02/18/25
+7.29 (+29.90%)
since 05/20/24

Most Recent Stories

More News
Alkermes' Q1 Earnings and Revenues Fall Short of Estimates

Alkermes plc ALKS reported earnings from continuing operations of 13 cents per share for first-quarter 2025, which missed the Zacks Consensus Estimate of 28 cents. The company had reported earnings of...

BEAM : 17.75 (+0.54%)
IMCR : 32.39 (+4.48%)
ADMA : 20.44 (+1.24%)
ALKS : 31.67 (+0.70%)
Alkermes: Q1 Earnings Snapshot

Alkermes: Q1 Earnings Snapshot

ALKS : 31.67 (+0.70%)
Do Options Traders Know Something About Alkermes Stock We Don't?

Investors in Alkermes plc ALKS need to pay close attention to the stock based on moves in the options market lately. That is because the Aug 15, 2025 $20.00 Call had some of the highest implied volatility...

ALKS : 31.67 (+0.70%)
Do Options Traders Know Something About Alkermes Stock We Don't?

Investors in Alkermes plc ALKS need to pay close attention to the stock based on moves in the options market lately. That is because the Aug 15, 2025 $20.00 Call had some of the highest implied volatility...

ALKS : 31.67 (+0.70%)
Alkermes Begins Idiopathic Hypersomnia Study on ALKS 2680

Alkermes plc ALKS announced that it has initiated the phase II Vibrance-3 study, evaluating the novel, investigational and oral orexin 2 receptor agonist, ALKS 2680, in adults with idiopathic hypersomnia...

KRYS : 131.54 (-0.56%)
JAZZ : 111.02 (+1.13%)
ALKS : 31.67 (+0.70%)
AXSM : 108.35 (+0.05%)
Alkermes' Q4 Earnings & Revenues Surpass Estimates, Stock Up

Alkermes plc ALKS reported adjusted earnings from continuing operations of $1.04 per share for fourth-quarter 2024, which beat the Zacks Consensus Estimate of 81 cents. The company had reported adjusted...

HRMY : 35.62 (-0.81%)
PCRX : 26.75 (+2.29%)
ALKS : 31.67 (+0.70%)
Alkermes Plc EPS Soars Past Forecasts

Alkermes reported strong earnings by exceeding both revenue and earnings expectations in its latest quarterly release.

ALKS : 31.67 (+0.70%)
Alkermes: Q4 Earnings Snapshot

Alkermes: Q4 Earnings Snapshot

ALKS : 31.67 (+0.70%)
Insider Sale: EVP R&D of $ALKS (ALKS) Sells 61,151 Shares

Craig C. Hopkinson, the EVP R&D of $ALKS ($ALKS), sold 61,151 shares of the company on 12-09-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 56.2% of their...

ALKS : 31.67 (+0.70%)
Are Options Traders Betting on a Big Move in Alkermes (ALKS) Stock?

Investors in Alkermes PLC ALKS need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 20, 2024 $40.00 Call had some of the highest implied volatility...

ALKS : 31.67 (+0.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Alkermes plc, formed by the merger of Waltham, MA-based Alkermes, Inc. and Elan Drug Technologies (EDT), is a fully integrated global biopharmaceutical company that utilizes proprietary technologies to research, develop and commercialize, both with partners and on its own pharmaceutical products in major...

See More

Key Turning Points

3rd Resistance Point 32.35
2nd Resistance Point 32.05
1st Resistance Point 31.86
Last Price 31.67
1st Support Level 31.37
2nd Support Level 31.07
3rd Support Level 30.88

See More

52-Week High 36.45
Last Price 31.67
Fibonacci 61.8% 31.27
Fibonacci 50% 29.67
Fibonacci 38.2% 28.08
52-Week Low 22.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
OSZAR »